Fungal Infections Caused by Kazachstania spp., Strasbourg, France, 2007-2020.


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
01 2022
Historique:
entrez: 21 12 2021
pubmed: 22 12 2021
medline: 7 1 2022
Statut: ppublish

Résumé

Rare fungal pathogens are emerging as agents of invasive fungal infections. We analyzed 13 cases of fungal infections caused by Kazachstania (Arxiozyma) spp. in Strasbourg University Hospital, Strasbourg, France. Among the cases, 4 patients had proven fungal disease (3 cases of invasive fungal disease and 1 mucocutaneous infection) and 9 were colonized by Kazachstania (Arxiozyma) spp. Candida albicans was also isolated from 11 of the 13 patients. None of the patients with proven invasive fungal disease met host criteria, but most had underlying diseases. All strains were identified as K. telluris by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and 3 were confirmed as K. bovina by internal transcribed spacer sequencing. For all tested strains, the MICs for fluconazole were >2 μg/mL. Emergence of this rare fungal infection might be explained by the increasing number of patients with immunocompromised conditions and gastroesophageal diseases.

Identifiants

pubmed: 34932452
doi: 10.3201/eid2801.211543
pmc: PMC8714217
doi:

Substances chimiques

Antifungal Agents 0
Fluconazole 8VZV102JFY

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-34

Références

J Clin Microbiol. 2005 Jan;43(1):101-11
pubmed: 15634957
Clin Microbiol Infect. 2014 Apr;20 Suppl 3:76-98
pubmed: 24102785
Antimicrob Agents Chemother. 2021 May 18;65(6):
pubmed: 33820766
Antonie Van Leeuwenhoek. 1958;24(2):137-44
pubmed: 13595640
Emerg Infect Dis. 2014 Jul;20(7):1149-55
pubmed: 24960557
J Mycol Med. 2021 Jun;31(2):101109
pubmed: 33422936
Emerg Infect Dis. 2020 Mar;26(3):626-627
pubmed: 32091374
Antonie Van Leeuwenhoek. 1957;23(1):23-9
pubmed: 13425510
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376
pubmed: 31802125
J Infect. 2020 Nov;81(5):802-815
pubmed: 32798532
PLoS One. 2012;7(3):e32278
pubmed: 22396754
Med Mycol. 2015 May;53(4):313-37
pubmed: 25802363

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH